Sony/ATV extends deal with Geoff Warburton

Sony/ATV extends deal with Geoff Warburton

Sony/ATV has extended its worldwide deal with songwriter and musician Geoff Warburton, the publisher has announced.

Warburton is a main collaborator of Shawn Mendes, and co-wrote a number of songs on the Canadian’s first two albums, including UK and US No.1 single There’s Nothing Holdin’ Me Back, which has sold 1,045,109 copies in Britain and secured double-platinum status in America. 

Warburton also co-wrote Mendes’ current single, In My Blood, which became one of the Top 5 most streamed songs globally on Spotify within a day of release in March. The track has 132,071 UK sales to date.

The new agreement covers both Warburton’s catalogue and future works.

Danny Strick, Sony/ATV co-president, US said: “Geoff Warburton is an incredibly gifted writer whose songs have played a significant role in Shawn Mendes’ success around the world. We are very excited to continue our long association with him in what will be an exciting next career chapter.”

Sony/ATV senior director of A&R, Clio Massey, said: “It’s been a joy to work with Geoff since early on in his career and to see the development of his craft and his growth as a songwriter. We’re so happy to get to continue working with him and are excited for the future.”

Warburton said: “I’m so thrilled to re-sign with Sony/ATV. They’ve been such an amazing partner as a publisher and I can’t wait to keep the work going with them.”

The Toronto musician’s manager, Andrew Gertler, said: “With hits like Holdin’ Me Back over the past year and writing on much of Shawn Mendes’ coming album, Clio, Danny, and the entire Sony/ATV have done an excellent job nurturing Geoff’s career as a writer and it only felt natural to continue his relationship with them. I can’t wait to see what the future holds for the partnership.”

Recently, Warburton has been based in Los Angeles and Nashville, writing pop, country and country-pop songs.

For more stories like this, and to keep up to date with all our market leading news, features and analysis, sign up to receive our daily Morning Briefing newsletter

subscribe link free-trial link

follow us...